secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEOGEN CORP (NEOG)
CIK:        0000711377
Form:       8-K
Filed at:   2024-10-01T23:59:59+00:00
Accession:  0000950170-24-110564
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Neogen appoints QIAGEN CEO Thierry Bernard to board of directors
----------------------------------------------------------------

- Thierry Bernard appointed to Neogen Board of Directors, effective November 1, 2024.
- Bernard is CEO of QIAGEN N.V. (NYSE: QGEN), a global molecular insights provider.
- Bernard previously held senior roles at bioMérieux SA over 15 years.
- Board determined Bernard qualifies as independent under Nasdaq listing standards.
- Board Chair Jim Borel highlighted Bernard's science and technology expertise.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/711377/000095017024110564/0000950170-24-110564-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/711377/000095017024110564/neog-20240925.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-110564

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer